Literature DB >> 23921325

Should postoperative pulmonary function be a criterion that affects upper instrumented vertebra selection in adolescent idiopathic scoliosis surgery?

Satoru Demura1, Tracey P Bastrom, John Schlechter, Burt Yaszay, Peter O Newton.   

Abstract

STUDY
DESIGN: A multicenter, prospective evaluation of pulmonary function testing (PFT) and radiographical measures in patients surgically treated for adolescent idiopathic scoliosis (AIS).
OBJECTIVE: The objective of this study was to evaluate pulmonary function to determine whether a more proximal upper instrumented vertebra (UIV) negatively impacts pulmonary function in patients surgically treated for AIS. SUMMARY OF BACKGROUND DATA: There seems to be increasing concern that a more proximal extent of posterior thoracic spinal instrumentation and fusion reduces postoperative pulmonary function. However, there are few reports that analyze the relation between the selection of UIV and pulmonary function in AIS.
METHODS: PFT and radiographical examination of 154 patients with major thoracic AIS (Lenke type 1-4) undergoing posterior thoracic spinal instrumentation and fusion without thoracoplasty were completed prospectively. Patients were divided into groups based on UIV (T1-T3 vs. T4-T5) and Lenke curve type (2 and 4 vs. 1 and 3) and analyzed respectively. Demographic, radiographical measurements, and PFT data from preoperative and 2-year time points were analyzed.
RESULTS: Patients with a structural upper thoracic curve (Lenke 2 and 4) had significantly lower preoperative PFT values than those without a structural upper thoracic curve (Lenke 1 and 3). Lenke 2 and 4 patients were also more likely to be fused proximally (82%, T1-T3) than those in the Lenke 1 and 3 groups (42%, T1-T3, P< 0.05). Preoperatively, those with UIV from T1 to T3 tended to have lower PFT values than those with UIV from T4-T5; however, only percent total lung capacity was statistically different (P< 0.05). Both UIV groups showed significant increases in all absolute values (forced vital capacity, forced expiratory volume in 1s, total lung capacity) at 2-year follow-up (P< 0.05) as expected with growth, and the percent predicted values (% forced vital capacity, % forced expiratory volume in 1s, % total lung capacity) remained stable.
CONCLUSION: Although patients with UIV: T1-T3 showed slightly lower PFT values than UIV: T4-T5, the presence of a double thoracic curve was the primary cause of PFT reduction in these patients. Including the upper thoracic spine in the fusion had no significant effect on pulmonary function 2 years after surgical correction of AIS. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2013        PMID: 23921325     DOI: 10.1097/BRS.0b013e3182a637a8

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Impact of fusion for adolescent idiopathic scoliosis on lung volume measured with computed tomography.

Authors:  Nobuyuki Fujita; Mitsuru Yagi; Takehiro Michikawa; Yoshitake Yamada; Satoshi Suzuki; Osahiko Tsuji; Narihito Nagoshi; Eijiro Okada; Takashi Tsuji; Masaya Nakamura; Morio Matsumoto; Kota Watanabe
Journal:  Eur Spine J       Date:  2019-06-08       Impact factor: 3.134

Review 2.  A comprehensive review of thoracic deformity parameters in scoliosis.

Authors:  Jonathan A Harris; Oscar H Mayer; Suken A Shah; Robert M Campbell; Sriram Balasubramanian
Journal:  Eur Spine J       Date:  2014-09-20       Impact factor: 3.134

3.  Does pulmonary function improve after surgical correction of adult idiopathic scoliosis?

Authors:  Hiroaki Nakashima; Noriaki Kawakami; Tetsuya Ohara; Toshiki Saito; Ryoji Tauchi; Shiro Imagama; Gregory J Redding
Journal:  Spine Deform       Date:  2021-06-27

Review 4.  Does Posterior Scoliosis Correction Improve Respiratory Function in Adolescent Idiopathic Scoliosis? A Systematic Review and Meta-analysis.

Authors:  So Kato; Jean-Christophe Murray; Mario Ganau; Yongyao Tan; Yasushi Oshima; Sakae Tanaka
Journal:  Global Spine J       Date:  2018-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.